Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys

Behavioural Pharmacology

Volumn 11, Issue 7-8, 2000, Pages 535-553

  Winsauer, P J ^a   Moerschbaecher, J M ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT(1A) receptors; 5 HT(2A) receptors; Learning; Monkey; Repeated acquisition; Serotonin

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 DIPROPYLAMINO 1,3,4,5 TETRAHYDROBENZ[CD]INDOLE 6 CARBOXAMIDE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 4 IODO N [2 [4 (METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N 2 PYRIDINYLBENZAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RITANSERIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; LEARNING; MALE; NONHUMAN; RAT; RECEPTOR AFFINITY; RHESUS MONKEY; SEROTONINERGIC SYSTEM;

EID: 0033634810     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200011000-00002     Document Type: Article

References (56)

1. The 5-HT1A receptor antagonist p-MPPI blocks responses mediated by postsynaptic and presynaptic 5-HT1A receptors
2. 5-Hydroxytryptamine 2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex
3. Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats
4. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI
5. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors
6. 5-HT receptors as targets for the development of novel anxiolytic drugs: Models, mechanisms and future directions
7. Buspirone impairs performance of a three-choice working memory water escape task in rats
8. 5-HT2 receptor subtypes: A family re-united?
9. Antidepressant-like effect of LY228729 as measured in the rodent forced swim paradigm
10. Antagonism of 8-OH-DPAT-induced behaviour in rats
11. 8-Hydroxy-2-(di-n-propylamino)tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task
12. Involvement of 5-hydroxytryptamine 2A (5-HT2A) receptors in the mediation of the discriminative stimulus properties of (+/-)DOI in rats
13. Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists
14. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist
15. Beyond the serotonin reuptake inhibitors: Rationales for the development of new serotonergic agents
16. Response suppression induced with selective 5-HT agonists can be differentially blocked with LY53857 in an animal model of depression
17. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist
18. Preclinical studies on LY228729: A potent and selective serotonin1A agonist
19. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635
20. Acute effects of LSD on rhesus monkey operant test battery performance
21. Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes
22. Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)
23. Stimulus properties of hallucinogenic phenalkylamines and related designer drugs: Formulation of structure-activity relationships
24. Serotonin receptors: Clinical implications
25. Serotonin receptor subtypes
26. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors
27. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT
28. The putative 5-HT1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro
29. Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey
30. Effects of the serotonin agonists 8-OH-DPAT, buspirone, and DOI on water maze performance
31. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon
32. Role of 5-HT1A receptors in the ability of mixed 5-HT1A receptor agonist/dopamine D2 receptor antagonists to inhibit methylphenidate-induced behaviors in rats
33. A potential 5-HT1A receptor antagonist: p-MPPI
34. 125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: In vitro binding and autoradiographic studies
35. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist
36. Dexfenfluramine and serotonin neurotoxicity: Further preclinical evidence that clinical caution is indicated
37. Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in learning
38. Effects of the 5-HT receptor antagonists GR127935 (5-HT1B/1D) and MDL100907 (5-HT2A) in the consolidation of learning
39. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: A comparative pharmacological characterization with proposed 5-HT1A antagonists
40. Effects of kappa agonists and dexoxadrol on the acquisition of conditional discriminations in monkeys
41. The hallucinogens
42. The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(DI-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat
43. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task
44. NAN-190: Agonist and antagonist interactions with brain 5-HT1A receptors
45. Hallucinogenic drug interactions at human brain 5-HT2 receptors: Implications for treating LSD-induced hallucinogenesis
46. A primate model for the study of hallucinogens
47. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding
48. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA)
49. Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: Effects of scopolamine, 8-OH-DPAT and EAA antagonists
50. Effects of novel 5-HT1A receptor antagonists on measures of post- synaptic 5-HT1A receptor activation in vivo
51. Repeated acquisition as a behavioral base line for studying drug effects
52. Comparison of the effects of typical and atypical anxiolytics on learning in monkeys and rats
53. Cannabinoid ligands and their effects on learning and performance in rhesus monkeys
54. Full and partial 5-HT1A receptor agonists disrupt learning and performance in rats
55. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: A possible role for 5-HT1A receptors in memory